Pfizer logo

Latest headlines

Pfizer News

The latest Pfizer (PFE) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these PFE headlines next to the live Pfizer Fear and Greed Index.

Latest Pfizer Headlines48

Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?

fool.com · Jul 31, 2026

Pfizer's Bear Case Is Breaking

seekingalpha.com · Jul 31, 2026

Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock

zacks.com · Jul 31, 2026

Pfizer: Still Mispriced By Mr. Market (Earnings Preview)

seekingalpha.com · Jul 31, 2026

Pfizer (PFE) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates

zacks.com · Jul 30, 2026

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

reuters.com · Jul 30, 2026

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

businesswire.com · Jul 30, 2026

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

globenewswire.com · Jul 29, 2026

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

globenewswire.com · Jul 29, 2026

Europäische Kommission genehmigt Marktzulassung des an XFG angepassten COVID-19-Impfstoffs von Pfizer und BioNTech in der Europäischen Union

globenewswire.com · Jul 29, 2026

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

businesswire.com · Jul 29, 2026

Pfizer Stock Ahead of Q2 Earnings: To Buy or Not to Buy?

zacks.com · Jul 29, 2026

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

zacks.com · Jul 29, 2026

Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing

zacks.com · Jul 28, 2026

Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

zacks.com · Jul 28, 2026

Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far

seekingalpha.com · Jul 27, 2026

3 Absurdly Cheap Dividend Stocks to Buy Before August

fool.com · Jul 26, 2026

Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' July DiviDogs

seekingalpha.com · Jul 26, 2026

Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.

fool.com · Jul 25, 2026

Is Pfizer's 7% Dividend Yield Too Good to Be True? Here's the Straight Answer

fool.com · Jul 23, 2026

PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use

zacks.com · Jul 23, 2026

Pfizer's prostate cancer drug combination gets US FDA priority review

reuters.com · Jul 22, 2026

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

businesswire.com · Jul 22, 2026

What to Watch in Pfizer's Non-Oncology Portfolio This Earnings Season

zacks.com · Jul 21, 2026

Pfizer (PFE) Falls More Steeply Than Broader Market: What Investors Need to Know

zacks.com · Jul 20, 2026

Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

zacks.com · Jul 20, 2026

Could Pfizer Ultimately Be the Biggest Winner in the $100 Billion Weight-Loss Market?

fool.com · Jul 20, 2026

Looking for Cheap Income Stocks? Why Pfizer Belongs on Your Shortlist Right Now

fool.com · Jul 19, 2026

AI Bubble Risks Make Dividend Stocks Attractive Again

seekingalpha.com · Jul 18, 2026

Pfizer Paid Out $14.6 Billion in Dividends Over the Last 18 Months. Can It Keep This Up Through the Patent Cliff?

fool.com · Jul 18, 2026

Dividend Champion, Contender, And Challenger Highlights: Week Of July 19

seekingalpha.com · Jul 17, 2026

3 High-Yield Dividend Stocks to Buy and Hold

fool.com · Jul 17, 2026

Pfizer Stock Below 50-Day and 200-Day SMA: Buy the Dip or Exit Now?

zacks.com · Jul 16, 2026

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

globenewswire.com · Jul 16, 2026

3 of the Best Stocks to Buy for Less Than $100 Right Now

fool.com · Jul 14, 2026

Here's How Pfizer's Oncology Growth Story Looks Ahead of Q2 Results

zacks.com · Jul 14, 2026

Pfizer Has the Highest-Yielding Dividend in the S&P 500. Should Investors Be Worried?

fool.com · Jul 14, 2026

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

fool.com · Jul 14, 2026

Pfizer (PFE) Advances While Market Declines: Some Information for Investors

zacks.com · Jul 13, 2026

How To Build A $50,000 Dividend Portfolio In Today's Market

seekingalpha.com · Jul 13, 2026

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions

marketbeat.com · Jul 13, 2026

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (July 2026)

seekingalpha.com · Jul 11, 2026

Pfizer: The AI Hedge That Pays You To Stay Defensive

seekingalpha.com · Jul 11, 2026

July Graham Value All-Stars (GVAS) Emit 10 Beaming Buys

seekingalpha.com · Jul 11, 2026

Pfizer: The Post-Pandemic Turnaround Is Already Underway

seekingalpha.com · Jul 11, 2026

Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market?

fool.com · Jul 10, 2026

Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?

zacks.com · Jul 10, 2026

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

businesswire.com · Jul 10, 2026

Why Is Pfizer Up or Down Today?

When Pfizer (PFE) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a PFE move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Pfizer is up or down today.

How Pfizer News Affects the Price

News does not move the Pfizer (PFE) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Pfizer Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Pfizer trading volume. That is the chain to watch: headline, sentiment, volume, then the PFE price.

Trade the Pfizer News With Sentiment

Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Pfizer trading volume spike on a big story, check the Pfizer price history for context, follow the live PFE price, see the Pfizer price prediction, and read the Pfizer Fear and Greed Index for mood.

How do you feel about Pfizer?

1D

Frequently asked questions

Why is Pfizer up or down today?
Pfizer (PFE) moves on news, and the headlines above are the fastest way to see what is driving PFE today, from earnings, guidance and analyst moves to the broader market mood. Cross-check the reaction against the live Pfizer Fear and Greed Index and PFE trading volume.
What is the latest Pfizer news?
The newest Pfizer (PFE) headlines are listed above, most recent first, each linking to the original source. We pull the last 60 stories so you can scroll the full recent PFE news cycle in one place.
Where does Pfizer news come from?
We aggregate Pfizer (PFE) headlines from financial news wires and refresh them continuously. Each headline links straight to the original source.
How often is Pfizer news updated?
Continuously. The Pfizer (PFE) feed refreshes as new stories are published, so the headlines at the top are the freshest available.
How does Pfizer news relate to its Fear and Greed Index?
News drives sentiment, and sentiment drives price. A run of negative headlines tends to push the Pfizer Fear and Greed Index toward fear, positive coverage toward greed. Reading them together is how you separate noise from a real shift in mood.

Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.

About CFGI

The per-asset sentiment record.

CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.

Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.